<DOC>
	<DOCNO>NCT00868829</DOCNO>
	<brief_summary>The experimental design multi-center , prospective , non-controlled , non-randomized , single-arm clinical registry trial . The study enroll 5,000 patient receive Firebird2TM Cobalt-ChromiumAlloyed Sirolimus-Eluting Stent implantation . For patient multivessel disease , Firebird 2TM Stent implant . The enrollment patient take 4 month . Clinical follow-up 30 day , 6 month , 12 month , 24 month 36 month . Patients withdraw study due reason replace .</brief_summary>
	<brief_title>Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial</brief_title>
	<detailed_description>[ Definition management adverse event ] Adverse event refers undesirable clinical event . It may cause device , rapamycin , procedure related complication , adjunctive medication ( aspirin , clopidogrel , ticlopidine , anti-platelet agent ) use study . Self report adverse event patient encourage . Patients right inquire information adverse event time study . If adverse event confirm , investigator collect relate information complete Adverse Event Form . [ Classification adverse event severity ] Mild : Mild adverse event refers clinical event interfere patient 's daily activity . Moderate : Moderate adverse event refers clinical event affect patient 's daily activity . Serious : Serious adverse event refers clinical event result patient 's inability undertake daily activity . [ Management adverse event ] All adverse event occur study period document Adverse Event Forms . Investigators provide appropriate treatment adverse event follow patient symptom ( ) disappear remain stable [ Documents Recordkeeping ] All CRFs original supporting file ( informed consent , lab report , process record , medical history , result physical examination diagnosis , diagnosis , procedure date record regard equipment management ) must set secure central location research site staff maintain least 2 year upon notification termination completion trial issue MicroPort Medical . In case person charge keep file keep trial record continuously due retirement , transfer reason , recordkeeping hand another person able accept task , write notification successor 's name address send MicroPort Ethics Committee .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Ageâ‰§18 year 2 . Patient suitable candidate implantation drugeluting stent physician 's discretion 3 . Patient multivessel disease receive Firebird2 Stent 4 . Patient agrees provide informed consent follow clinical trial protocol , include medication , baseline followup visit procedure . 1 . Patient suitable candidate implantation drugeluting stent physician 's discretion 2 . Patient multivessel disease receive type stent instead Firebird2 Stent 3 . Patient receive PCI intervention , rotablation , directional coronary atherectomy ( DCA ) , TEC , CRA , laser angioplasty , etc . ) , addition PTCA stenting 4 . Patient refuse provide inform consent 5 . Patient able follow clinical trial protocol , include medication , baseline followup visit procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Stent</keyword>
	<keyword>FireBird2</keyword>
	<keyword>Coronary Heart Disease</keyword>
</DOC>